🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationInternational compounding regulations — 6 month update Page 2

International compounding regulations — 6 month update

Admin Thu, Nov 13, 2025 at 11:41 AM 12 replies 1,033 viewsPage 2 of 3
DadBodDave
Member
187
923
Nov 2024
Ohio
Nov 13, 2025 at 2:31 PM#6

This is super helpful. So the bottom line is: if I want the smoothest experience, I should find a 503B outsourcing facility that's licensed in my state, rather than trying to use a local 503A pharmacy?

13 14laura_annarbor, JenMemphis, pat_auckland and 10 others
Reply Quote Save Share Report
rick_sfbay
Member
289
1,234
Jan 2025
San Francisco, CA
Nov 13, 2025 at 2:48 PM#7

Generally yes, for GLP-1 peptides specifically. 503B facilities have the federal registration that smooths over most state-to-state issues. Just verify they're licensed in your state before placing an order — most will list their state licenses on their website.

And keep in mind this landscape changes constantly. What's true today might not be true in 6 months, especially with FDA enforcement actions ramping up.

Last edited: Nov 13, 2025 at 8:48 PM
14 16NicoleRaleigh, james_edin, FranDenver and 11 others
Reply Quote Save Share Report
HealthEcon_DC
Member
567
3,456
Apr 2024
Washington, DC
Nov 13, 2025 at 3:05 PM#8

One more thing — regardless of which state you're in, always check the FDA's list of registered outsourcing facilities. If a 503B claims to be registered but isn't on that list, that's a major red flag. The list is publicly available and searchable. Takes 2 minutes to verify. 📋

16 23KevinCompounds, TirzTom, TrialTracker_MD and 13 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register